Kilitch Drugs (India) Limited — Others, 15-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Kilitch Drugs (India) Ltd. has announced a board meeting to discuss the financial results for the quarter and half-year ended 31st March 2025. The company has received a confirmation certificate from MUFG Intime India Private Limited, its Registrar and Share Transfer Agent, indicating that securities received for dematerialization during this period were processed and have been listed on the relevant stock exchanges. This update ensures compliance with procedural standards and may enhance investor confidence in the company's operational transparency. The positive outlook around efficient share handling and governance can bolster shareholder sentiment.